News Features What’s in a Name: Is It Time to Choose Between TAVI and TAVR? Yael L. Maxwell March 27, 2025
News Conference News CRT 2025 SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years L.A. McKeown March 10, 2025
News Daily News Reinterventions Rare Yet Predictable After TAVI, French Registries Show Caitlin E. Cox March 05, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2025 Shelley Wood February 28, 2025
Presentation Miami Valves 2025 A Case of Severe Bioprosthetic Valve Dysfunction Presenter: Som Bailey January 30, 2025
News Conference News STS 2025 Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival Yael L. Maxwell January 27, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2024 Shelley Wood December 03, 2024
News Conference News PCR London Valves 2024 Newest Sapien TAVI Equals Surgery in Patients With Small Aortic Annuli at 5 Years Michael O'Riordan November 27, 2024
Presentation AHA 2024 Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement Presenter: Chisato Izumi November 17, 2024
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
Presentation TCT 2024 TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States Presenter: Philippe Genereux October 30, 2024
Presentation TCT 2024 Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials Presenter: Mahesh Madhavan October 30, 2024
Presentation TCT 2024 Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients Presenter: Julien Ternacle October 30, 2024
Presentation TCT 2024 Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability Presenter: Philippe Pibarot October 30, 2024
Presentation TCT 2024 Lessons Learned From the SMART Trial Presenter: Howard Herrmann October 30, 2024
Presentation TCT 2024 Transcatheter VIV (With Appropriate Leaflet Modification) Will Dominate! Presenter: Adam Greenbaum October 30, 2024
Presentation TCT 2024 Re-Do Surgery has Clear Long-Term Advantages and is Preferred! Presenter: Michael Bowdish October 30, 2024
Presentation TCT 2024 Electrosurgery Leaflet Modification – Technique and Results After BASILICA Presenter: Jaffar Khan October 30, 2024
Presentation TCT 2024 Mechanical Leaflet Modification – Technique and Results After SHORTCUT Presenter: Danny Dvir October 30, 2024